Correcting lies posted elsewhere: IPIX financing i
Post# of 72447
(Total Views: 907)
Posted On: 08/22/2017 10:15:36 PM
Correcting lies posted elsewhere: IPIX financing is far from toxic. There has been very little dilution given the length of time this agreement has been in place, and what the company has achieved with very little cash outlay (for a developing biotech). The financing deal was structured in a way that does not let Aspire call the shots -- they have to buy when the company tells them to.
Many of us have been invested in companies like OCAT that took on a lot of debt and had truly toxic deals -- in OCAT's case, they ended up having to sell the company for much less than it was worth, and long-time shareholders took a bath. Leo Ehrlich has avoided that kind of toxic financing and debt.
It is a lie that there was selling pressure today. There was VERY little activity today until the last half hour. 88k volume till about 3:45, then whammo, suddenly over 60k shares. On the other site, Daubers said he couldn't get a fill, and saw other orders filled around his bid. Other people told me the same thing.
We know that some market makers mark things as sells when they were actually buys, and the rules for how they mark them are strange to start with.
It was VERY HARD to buy stock today because there seemed to be no supply.
As far as the desperate claim that IPIX has "no drugs," that would be news to the FDA, the many clinical trial sites, and the patients who have been getting treated with something.
"Scam" companies don't have 5 successful clinical trials. Want to see what a scam looks like? There are any number of companies that haven't managed to execute a single Phase 1 clinical trial, after years of existence. For example, look at NNVC.
Oh, and as far as multi-identity calling up Leo Ehrlich and "giving him a good talking to," I had to spend 10 minutes getting my cat to stop laughing.
Many of us have been invested in companies like OCAT that took on a lot of debt and had truly toxic deals -- in OCAT's case, they ended up having to sell the company for much less than it was worth, and long-time shareholders took a bath. Leo Ehrlich has avoided that kind of toxic financing and debt.
It is a lie that there was selling pressure today. There was VERY little activity today until the last half hour. 88k volume till about 3:45, then whammo, suddenly over 60k shares. On the other site, Daubers said he couldn't get a fill, and saw other orders filled around his bid. Other people told me the same thing.
We know that some market makers mark things as sells when they were actually buys, and the rules for how they mark them are strange to start with.
It was VERY HARD to buy stock today because there seemed to be no supply.
As far as the desperate claim that IPIX has "no drugs," that would be news to the FDA, the many clinical trial sites, and the patients who have been getting treated with something.
"Scam" companies don't have 5 successful clinical trials. Want to see what a scam looks like? There are any number of companies that haven't managed to execute a single Phase 1 clinical trial, after years of existence. For example, look at NNVC.
Oh, and as far as multi-identity calling up Leo Ehrlich and "giving him a good talking to," I had to spend 10 minutes getting my cat to stop laughing.
(4)
(0)